Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Antibiotic Prophylaxis in Lichtenstein Hernia Repair
NCT01264003Phase 4Completed
- Sponsor
- Dışkapı Yıldırım Beyazıt Training and Research Hospital
- Start
- May 2008
- Primary completion
- Dec 2010
- Modality
- Reversible Covalent Inhibitors
01
Overview
Phase 4, randomised, open-label trial of cefazolin in inguinal hernia (2 arms), sponsored by Dışkapı Yıldırım Beyazıt Training and Research Hospital. Primary endpoint: Surgical site infection rates at 30 days. Started May 2008; status: completed.
02
Drugs
cefazolin
03
Conditions
inguinal hernia
Beyond the preview
Go deeper on NCT01264003.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01264003.